Physician profile
Andrew J Wolfe
NPI 1275551020
$66,322.08
in general payments reported to CMS, 2019-2025
18 companies · $42K in 2025
The $42K reported for 2025 was more than what 98% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,018 · 2021: $1,552 · 2022: $1,169 · 2023: $765 · 2024: $7,807 · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $43K · Food and Beverage: $5,927 · Travel and Lodging: $2,312 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $42,743.46 |
| Food and Beverage | $5,926.81 |
| Travel and Lodging | $2,311.64 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $47,009.16 | 2024-2025 | |
| Allergan, INC. | $6,875.73 | 2019-2022 | |
| Sientra, INC. | $6,713.72 | 2019-2022 | |
| Tela Bio, INC. | $1,493.72 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $1,041.51 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Integra Lifesciences Corporation | $606.59 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Mentor Worldwide LLC | $544.94 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Davol INC. | $481.26 | 2022-2025 | Phasix Mesh |
| Innovation Technologies INC | $300.52 | 2022-2025 | Irrisept |
| Bard Peripheral Vascular, INC. | $246.30 | 2021 | |
| Rti Surgical, INC | $221.20 | 2022 | |
| Galderma Laboratories, L.P. | $203.03 | 2019-2022 | |
| Becton, Dickinson and Company | $199.82 | 2025 | Phasix Mesh |
| Apyx Medical Corporation | $156.88 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $133.76 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $49.02 | 2022-2023 | Bridion |
| Solta Medical, A Division of Bausch Health US, LLC | $24.37 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $20.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.